Jade Biosciences Inc (JBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 113,542 | 35,538 | 81,409 | 53,237 | 23,022 |
| Operating Income | -113,542 | -35,538 | -81,409 | -53,237 | -23,022 |
| Other Income | -13,810 | -11,441 | 5,944 | 1,751 | 62 |
| Pre-tax Income | -127,352 | -46,979 | -75,465 | -51,486 | -22,960 |
| Income Tax | 58 | N/A | 56 | 25 | 3 |
| Net Income Continuous | -127,410 | -46,979 | -75,521 | -51,511 | -22,963 |
| Net Income | $-127,410 | $-46,979 | $-75,521 | $-51,511 | $-22,963 |
| EPS Basic Total Ops | -3.19 | -14.89 | -100.70 | -73.68 | -65.61 |
| EPS Basic Continuous Ops | -4.06 | -14.89 | -100.63 | -73.86 | -65.54 |
| EPS Diluted Total Ops | -3.19 | -14.89 | -100.70 | -73.68 | -65.61 |
| EPS Diluted Continuous Ops | -4.06 | -14.89 | -100.63 | -73.86 | -65.54 |
| EPS Diluted Before Non-Recurring Items | -3.19 | -85.61 | -100.70 | -73.68 | -65.61 |
| EBITDA(a) | $-114,300 | $-35,538 | $-84,370 | $-54,079 | $-22,991 |